Cargando…

Imaging findings for response evaluation of ductal carcinoma in situ in breast cancer patients treated with neoadjuvant systemic therapy: a systematic review and meta-analysis

OBJECTIVES: In approximately 45% of invasive breast cancer (IBC) patients treated with neoadjuvant systemic therapy (NST), ductal carcinoma in situ (DCIS) is present. Recent studies suggest response of DCIS to NST. The aim of this systematic review and meta-analysis was to summarise and examine the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ploumen, Roxanne A. W., de Mooij, Cornelis M., Gommers, Suzanne, Keymeulen, Kristien B. M. I., Smidt, Marjolein L., van Nijnatten, Thiemo J. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326113/ https://www.ncbi.nlm.nih.gov/pubmed/37020070 http://dx.doi.org/10.1007/s00330-023-09547-7

Ejemplares similares

Pathologic complete response of ductal carcinoma in situ to neoadjuvant systemic therapy in HER2-positive invasive breast cancer patients: a nationwide analysis
por: Ploumen, Roxanne A. W., et al.
Publicado: (2023)

The influence of receptor expression and clinical subtypes on baseline [18F]FDG uptake in breast cancer: systematic review and meta-analysis
por: de Mooij, Cornelis M., et al.
Publicado: (2023)

Value of (18)F-FDG PET/CT for predicting axillary pathologic complete response following neoadjuvant systemic therapy in breast cancer patients: emphasis on breast cancer subtype
por: de Mooij, Cornelis M., et al.
Publicado: (2021)

ASO Author Reflections: Preoperative Prediction of Postmastectomy Radiation Therapy After Neoadjuvant Systemic Therapy
por: Samiei, Sanaz, et al.
Publicado: (2019)

Prediction of Primary Tumour and Axillary Lymph Node Response to Neoadjuvant Chemo(Targeted) Therapy with Dedicated Breast [18F]FDG PET/MRI in Breast Cancer
por: de Mooij, Cornelis M., et al.
Publicado: (2023)

Diagnostic performance of PET/computed tomography versus PET/MRI and diffusion-weighted imaging in the N- and M-staging of breast cancer patients
por: de Mooij, Cornelis Maarten, et al.
Publicado: (2020)

Diagnostic Accuracy of Different Surgical Procedures for Axillary Staging After Neoadjuvant Systemic Therapy in Node-positive Breast Cancer: A Systematic Review and Meta-analysis
por: Simons, Janine M., et al.
Publicado: (2019)

Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients
por: Goorts, Briete, et al.
Publicado: (2017)

Ductal carcinoma in situ: to treat or not to treat, that is the question
por: van Seijen, Maartje, et al.
Publicado: (2019)

Differences in degree of lesion enhancement on CEM between ILC and IDC
por: van Nijnatten, Thiemo JA, et al.
Publicado: (2019)

Diagnostic performance of standard breast MRI compared to dedicated axillary MRI for assessment of node-negative and node-positive breast cancer
por: Samiei, Sanaz, et al.
Publicado: (2020)

MRI-Based Radiomics Analysis for the Pretreatment Prediction of Pathologic Complete Tumor Response to Neoadjuvant Systemic Therapy in Breast Cancer Patients: A Multicenter Study
por: Granzier, Renée W. Y., et al.
Publicado: (2021)

PB.40. What happens to the ductal carcinoma in situ in HER2-positive cancers treated with neoadjuvant chemotherapy and trastuzumab?
por: Millican-Slater, R, et al.
Publicado: (2014)

Neoadjuvant Endocrine Therapy and Delays in Surgery for Ductal Carcinoma in Situ: Implications for the Coronavirus Pandemic
por: Williams, Austin D., et al.
Publicado: (2021)

Breast Ductal Carcinoma in Situ: Morphologic and Kinetic MRI Findings
por: Nadrljanski, Mirjan M., et al.
Publicado: (2013)

Comparing the Diagnostic Performance of Contrast-Enhanced Mammography and Breast MRI: a Systematic Review and Meta-Analysis
por: Neeter, Lidewij M.F.H., et al.
Publicado: (2023)

Population‐based study of the effect of preoperative breast MRI on the surgical management of ductal carcinoma in situ
por: Keymeulen, K. B. I. M., et al.
Publicado: (2019)

Axillary staging in breast cancer patients treated with neoadjuvant chemotherapy in two Dutch phase III studies
por: Vriens, Birgit E.P., et al.
Publicado: (2017)

Pathologic response of ductal carcinoma in situ to neoadjuvant systemic treatment in HER2-positive breast cancer
por: Groen, Emma J., et al.
Publicado: (2021)

Pathologic Response of Associated Ductal Carcinoma In Situ to Neoadjuvant Systemic Therapy: A Systematic Review
por: Wazir, Umar, et al.
Publicado: (2022)

Non-Calcified Ductal Carcinoma in Situ: Ultrasound and Mammographic Findings Correlated with Histological Findings
por: Cho, Kyu Ran, et al.
Publicado: (2008)

Ductal Carcinoma In Situ of the Breast
por: Lee, Richard J., et al.
Publicado: (2012)

ASO Visual Abstract: Neoadjuvant Endocrine Therapy and Delays in Surgery for Ductal Carcinoma in Situ: Implications for the Coronavirus Pandemic
por: Williams, Austin D., et al.
Publicado: (2021)

Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting
por: Habel, Laurel A, et al.
Publicado: (2009)

Growth pattern of ductal carcinoma in situ (DCIS): a retrospective analysis based on mammographic findings
por: Thomson, J Z, et al.
Publicado: (2001)

Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy
por: Giannakeas, Vasily, et al.
Publicado: (2018)

Treatment results in patients with ductal carcinoma in situ treated with adjuvant radiotherapy
por: GÜZELÖZ, Zeliha, et al.
Publicado: (2019)

Ductal carcinoma in situ (DCIS)
por: Holland, R
Publicado: (2002)

Breast Ductal Carcinoma In Situ
por: Sacchini, Virgilio, et al.
Publicado: (2012)

Identifying Good Candidates for Active Surveillance of Ductal Carcinoma In Situ: Insights from a Large Neoadjuvant Endocrine Therapy Cohort
por: Glencer, Alexa C., et al.
Publicado: (2022)

Dedicated Axillary MRI-Based Radiomics Analysis for the Prediction of Axillary Lymph Node Metastasis in Breast Cancer
por: Samiei, Sanaz, et al.
Publicado: (2021)

Ultrasound findings and histological features of ductal carcinoma in situ detected by ultrasound examination alone
por: Izumori, Ayumi, et al.
Publicado: (2009)

Tamoxifen Initiation After Ductal Carcinoma In Situ
por: Nichols, Hazel B., et al.
Publicado: (2016)

Radiological predictors of successful therapeutic wide local excision of ductal carcinoma in situ : findings from the Sloane project
por: Evans, A, et al.
Publicado: (2006)

Treatment outcome of ductal carcinoma in situ patients treated with postoperative radiation therapy
por: Lim, Yu Jin, et al.
Publicado: (2014)

Meta‐analysis of the impact of neoadjuvant therapy on patterns of recurrence in pancreatic ductal adenocarcinoma
por: Schorn, S., et al.
Publicado: (2018)

Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer
por: Wei, Zhang, et al.
Publicado: (2012)

Ductal carcinoma in situ (DCIS): are we overdetecting it?
por: Evans, A
Publicado: (2004)

Modeling Human Ductal Carcinoma In Situ in the Mouse
por: Behbod, Fariba, et al.
Publicado: (2018)

Gynecomastia and Malignancy: A Case of Male Invasive Ductal Breast Carcinoma Treated with Neoadjuvant Chemotherapy
por: Mekheal, Erinie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_umsnl2toa6h695mgqb59ike38n